by Jennifer P | Mar 12, 2021 | Canadian Regulatory, Cosmetics, U.S. Regulatory
The international nomenclature for hydrocarbon ingredients currently designated by INCI names containing the stem terms ‘isoparaffin’ and ‘pareth’ will be revised. ‘Isoalkane’ and ‘alketh’ will replace these terms, respectively, preceded by the appropriate carbon...
by Carley Lovnicki | Oct 9, 2020 | Cosmetics, U.S. Regulatory
This month two new bills were signed by the Governor of California, implementing new restrictions on cosmetic ingredients within the state. The first of these bills, titled AB-2762 (Cosmetic Products: Safety), includes a list of twelve substances, including Dibutyl...
by Emily C | May 12, 2020 | Canadian Regulatory, OTC Drugs, Research/Science/Technology, U.S. Regulatory, Uncategorized
Recently, Health Canada announced that the Regulatory Enrolment Process (REP) will be mandatory to use as of October 1, 2020. The Health Products and Food Branch (HPFB) will be implementing this single window for transmission of regulatory transactions in electronic...
by Jennifer P | Jan 16, 2019 | Canadian Regulatory
What is a risk assessment of a chemical substance? A risk assessment is an integral part of maintaining both the health of Canadians and the environment. Risk assessments are executed by Environment and Climate Change Canada under the CEPA (Canadian Environmental...
by Jennifer P | Jan 9, 2019 | Research/Science/Technology
A constant victim of media scrutiny, blue light has recently received a lot of negative press with regards to its damaging effects to the skin. Side effects such as hyperpigmentation and oxidative stress have been found to be associated with the exposure of...
Recent Comments